Camp4 Therapeutics Corporation

NasdaqGM:CAMP Stock Report

Market Cap: US$310.8m

Camp4 Therapeutics Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Josh Mandel-Brehm

Chief executive officer

US$2.3m

Total compensation

CEO salary percentage24.28%
CEO tenure9yrs
CEO ownership0.5%
Management average tenure3.3yrs
Board average tenure9yrs

Recent management updates

Recent updates

Here's Why Camp4 Therapeutics (NASDAQ:CAMP) Must Use Its Cash Wisely

Jul 02
Here's Why Camp4 Therapeutics (NASDAQ:CAMP) Must Use Its Cash Wisely

CEO Compensation Analysis

How has Josh Mandel-Brehm's remuneration changed compared to Camp4 Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-US$53m

Jun 30 2025n/an/a

-US$52m

Mar 31 2025n/an/a

-US$52m

Dec 31 2024US$2mUS$557k

-US$52m

Sep 30 2024n/an/a

-US$52m

Jun 30 2024n/an/a

-US$50m

Mar 31 2024n/an/a

-US$49m

Dec 31 2023US$696kUS$546k

-US$49m

Compensation vs Market: Josh's total compensation ($USD2.29M) is about average for companies of similar size in the US market ($USD2.29M).

Compensation vs Earnings: Josh's compensation has increased whilst the company is unprofitable.

CEO

Josh Mandel-Brehm (42 yo)

9yrs
Tenure
US$2,294,985
Compensation

Mr. Joshua Mandel-Brehm, also known as Josh, serves as an Independent Director at ProMIS Neurosciences, Inc. September 2021 and served as its Director since September 1, 2021. He has also been a founder an...

Leadership Team

NamePositionTenureCompensationOwnership
Joshua Mandel-Brehm
CEO, President & Director9yrsUS$2.29m0.54%
$ 1.7m
Richard Young
Founder & Independent Directorno dataUS$143.05k0.33%
$ 1.0m
Kelly Gold
Chief Financial Officerno dataUS$1.31m0.13%
$ 406.6k
Yuri Maricich
Chief Medical Officer2.4yrsUS$2.52m0.012%
$ 36.3k
Leonard Zon
Founder & Chairman of Scientific Advisory Boardno datano datano data
Caleb Moore
Chief Business Operations Officerno datano datano data
Daniel Tardiff
Chief Scientific Officerless than a yearno datano data
Michelle Gates
Senior VP & Chief People Officer4.5yrsno datano data
David Bumcrot
Senior Vice President of Researchno dataUS$501.93k0.12%
$ 369.8k
Alla Sigova
Senior Vice President of Platformno datano datano data
Satya Kuchimanchi
Senior Vice President of Technical Operations3.3yrsno datano data
3.3yrs
Average Tenure
48yo
Average Age

Experienced Management: CAMP's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Joshua Mandel-Brehm
CEO, President & Director9yrsUS$2.29m0.54%
$ 1.7m
Richard Young
Founder & Independent Director10yrsUS$143.05k0.33%
$ 1.0m
Leonard Zon
Founder & Chairman of Scientific Advisory Boardno datano datano data
Steven H. Holtzman
Independent Director6.3yrsUS$132.72k0.21%
$ 652.6k
Douglas Williams
Independent Chairmanless than a yearno data0.0048%
$ 15.0k
Amir Nashat
Independent Director11yrsno datano data
Michael Higgins
Independent Director9yrsUS$46.36k0.055%
$ 172.1k
Jay Shendure
Member of Scientific Advisory Boardno datano datano data
Benjamin Neale
Member of Scientific Advisory Boardno datano datano data
Karen Adelman
Member of Scientific Advisory Boardno datano datano data
Jason Buenrostro
Member of Scientific Advisory Boardno datano datano data
Joanna Wysocka
Member of Scientific Advisory Boardno datano datano data
9.0yrs
Average Tenure
65yo
Average Age

Experienced Board: CAMP's board of directors are considered experienced (9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/06 20:15
End of Day Share Price 2026/01/05 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Camp4 Therapeutics Corporation is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steven SeedhouseCantor Fitzgerald & Co.
Anupam RamaJ.P. Morgan
Eric JosephJ.P. Morgan